Rammes, 2008, Curr Neuropharmacol, 6, 55, 10.2174/157015908783769671
Seeman, 2008, Synapse, 62, 149, 10.1002/syn.20472
Kornhuber, 1989, Eur J Pharmacol, 166, 589, 10.1016/0014-2999(89)90384-1
La Spada, 2009, Nat Med, 15, 1355, 10.1038/nm1209-1355
Parsons, 1999, Neuropharmacology, 38, 735, 10.1016/S0028-3908(99)00019-2
Jones, 2010, Int J Geriatr Psychiatry, 25, 547, 10.1002/gps.2387
Farlow, 2008, Drug Saf, 31, 577, 10.2165/00002018-200831070-00003
Dolder, 2009, Am J Geriatr Psychiatry, 17, 170, 10.1097/JGP.0b013e318186bd7b
Dubey, 2009, E-J Chem, 6, 1063, 10.1155/2009/748492
Liu, 2008, Clin Ther, 30, 641, 10.1016/j.clinthera.2008.04.005
Kornhuber, 2007, Clin Pharmacokinet, 46, 599, 10.2165/00003088-200746070-00005
Periclou, 2006, Clin Pharmacol Ther, 79, 134, 10.1016/j.clpt.2005.10.005
Wesemann, 1983, Arzneimittelforschung, 33, 1122
Periclou, 2004, Ann Pharmacother, 38, 1389, 10.1345/aph.1D638
Yao, 2005, J Clin Pharmacol, 45, 519, 10.1177/0091270005274551
Shua-Haim, 2008, Clin Drug Investig, 28, 361, 10.2165/00044011-200828060-00004
Berk, 2007, Acta Psychiatr Scand, 116, 41, 10.1111/j.1600-0447.2007.01058.x
Cousins, 2009, Bipolar Disord, 11, 787, 10.1111/j.1399-5618.2009.00760.x
Diehl, 1992, Compr Psychiatry, 33, 115, 10.1016/0010-440X(92)90007-D
Serra, 1979, Life Sci, 25, 415, 10.1016/0024-3205(79)90573-3
Serra, 1992, Pharmacol Toxicol, 71, 72, 10.1111/j.1600-0773.1992.tb01631.x
Braestrup, 1975, Eur J Pharmacol, 34, 181, 10.1016/0014-2999(75)90238-1
Molander, 1976, Psychopharmacology (Berl), 49, 139, 10.1007/BF00427282
Randrup, 1977, Psychopharmacology (Berl), 53, 309, 10.1007/BF00492370
Serra, 1980, Pharmacol Res Commun, 12, 619, 10.1016/S0031-6989(80)80149-4
Spyraki, 1981, Eur J Pharmacol, 74, 195, 10.1016/0014-2999(81)90531-8
Serra, 1990, Brain Res, 527, 234, 10.1016/0006-8993(90)91142-4
Collu, 1997, Eur J Pharmacol, 322, 123, 10.1016/S0014-2999(97)00006-X
DʼAquila, 2000, Eur J Pharmacol, 405, 365, 10.1016/S0014-2999(00)00566-5
Kukopulos, 1980, Pharmakopsychiatr Neuropsychopharmakol, 13, 156, 10.1055/s-2007-1019628
DʼAquila, 2003, Eur J Pharmacol, 458, 129, 10.1016/S0014-2999(02)02731-0
DʼAquila, 2004, Eur J Pharmacol, 492, 61, 10.1016/j.ejphar.2004.04.008
Koukopoulos, 2009, Eur Psychiatry, 24, 125, 10.1016/j.eurpsy.2008.07.006
Leverich, 2006, Am J Psychiatry, 163, 232, 10.1176/appi.ajp.163.2.232
Tondo, 1981, Int Pharmacopsychiat, 16, 119, 10.1159/000468483
Tondo, 2010, Acta Psychiatr Scand, 121, 404, 10.1111/j.1600-0447.2009.01514.x
DʼAquila, 2000, Eur J Pharmacol, 395, 157, 10.1016/S0014-2999(00)00189-8
DʼAquila, 2001, Eur J Pharmacol, 416, 107, 10.1016/S0014-2999(01)00876-7
DʼAquila, 2006, Eur J Pharmacol, 535, 208, 10.1016/j.ejphar.2006.02.016
Nakagawa, 2011, PLoS One, 6, e24865, 10.1371/journal.pone.0024865
Prieto-Gomez, 2004, Life Sci, 74, 1581, 10.1016/j.lfs.2003.07.047
Acerbo, 2004, Behav Brain Res, 151, 201, 10.1016/j.bbr.2003.08.021
Broadbent, 2003, Psychopharmacology (Berl), 167, 225, 10.1007/s00213-003-1404-3
Pacchioni, 2002, Ann N Y Acad Sci, 965, 233, 10.1111/j.1749-6632.2002.tb04165.x
DʼAquila, 1992, Eur J Pharmacol, 224, 199, 10.1016/0014-2999(92)90805-E
DʼAquila, 1997, Eur J Pharmacol, 330, 11, 10.1016/S0014-2999(97)01019-4
Koukopoulos, 2010, Bipolar Disord, 12, 348, 10.1111/j.1399-5618.2010.00803.x
Meloni, 1993, Pharmacol Biochem Behav, 46, 423, 10.1016/0091-3057(93)90374-3
De Montis, 1993, Brain Res, 606, 63, 10.1016/0006-8993(93)91570-I
Ongür, 2008, Biol Psychiatry, 64, 718, 10.1016/j.biopsych.2008.05.014
Duman, 2004, Neuromolecular Med, 5, 11, 10.1385/NMM:5:1:011
MacQueen, 2003, Proc Natl Acad Sci U S A, 100, 1387, 10.1073/pnas.0337481100
Videbech, 2004, Am J Psychiatry, 161, 1957, 10.1176/appi.ajp.161.11.1957
Gao, 2011, Psychiatry Res, 188, 366, 10.1016/j.psychres.2010.12.030
Keck, 2009, Clin Neuropharmacol, 32, 199, 10.1097/WNF.0b013e318184fae2
Koukopoulos, 2012, J Affect Disord, 136, 163, 10.1016/j.jad.2011.09.040
Spearing, 1997, Psychiatry Res, 73, 159, 10.1016/S0165-1781(97)00123-6
Gauthier, 2010, Int Psychogeriatr, 22, 346, 10.1017/S1041610209991505
Anand, 2012, Bipolar Disord, 14, 64, 10.1111/j.1399-5618.2011.00971.x
Kim, 1982, Arch Psychiatr Nervenkr, 232, 299, 10.1007/BF00345492
Levine, 2000, Biol Psychiatry, 47, 586, 10.1016/S0006-3223(99)00284-X
Sanacora, 2004, Arch Gen Psychiatry, 61, 705, 10.1001/archpsyc.61.7.705
Nudmamud-Thanoi, 2004, Neurosci Lett, 372, 173, 10.1016/j.neulet.2004.09.035
Beneyto, 2007, Neuropsychopharmacology, 32, 1888, 10.1038/sj.npp.1301312
Maeng, 2007, Curr Psychiatry Rep, 9, 467, 10.1007/s11920-007-0063-1
Koike, 2011, Behav Brain Res, 224, 107, 10.1016/j.bbr.2011.05.035
Zarate, 2006, Arch Gen Psychiatry, 63, 856, 10.1001/archpsyc.63.8.856
aan het Rot, 2010, Biol Psychiatry, 67, 139, 10.1016/j.biopsych.2009.08.038
Price, 2009, Biol Psychiatry, 66, 522, 10.1016/j.biopsych.2009.04.029
Larkin, 2011, Int J Neuropsychopharmacol, 14, 1127, 10.1017/S1461145711000629
Réus, 2010, Brain Res Bull, 81, 585, 10.1016/j.brainresbull.2009.11.013
Castrén, 2010, Dev Neurobiol, 70, 289, 10.1002/dneu.20758
Quan, 2011, Neuroscience, 182, 88, 10.1016/j.neuroscience.2011.03.026
Feyissa, 2009, Prog Neuropsychopharmacol Biol Psychiatry, 33, 70, 10.1016/j.pnpbp.2008.10.005
Ferguson, 2007, Clin Neuropharmacol, 30, 136, 10.1097/WNF.0b013e3180314ae7
Zarate, 2006, Am J Psychiatry, 163, 153, 10.1176/appi.ajp.163.1.153
Muhonen, 2008, J Clin Psychiatry, 69, 392, 10.4088/JCP.v69n0308
Muhonen, 2008, Subst Abuse Treat Prev Policy, 3, 20, 10.1186/1747-597X-3-20
Munoz, 2008, J Neuropsychiatry Clin Neurosci, 20, 119, 10.1176/appi.neuropsych.20.1.119
Kollmar, 2008, Aust N Z J Psychiatry, 42, 170, 10.1080/00048670701787628
Tsapakis, 2002, Adv Psychiatr Treat, 8, 189, 10.1192/apt.8.3.189
Farber, 2003, Ann N Y Acad Sci, 1003, 119, 10.1196/annals.1300.008
Kim, 1980, Neurosci Lett, 20, 379, 10.1016/0304-3940(80)90178-0
Krystal, 1994, Arch Gen Psychiatry, 51, 199, 10.1001/archpsyc.1994.03950030035004
Javitt, 1991, Am J Psychiatry, 148, 1301, 10.1176/ajp.148.10.1301
Pilowsky, 2006, Mol Psychiatry, 11, 118, 10.1038/sj.mp.4001751
Gilmour, 2009, Psychopharmacology (Berl), 205, 203, 10.1007/s00213-009-1530-7
Dingledine, 1999, Pharmacol Rev, 51, 7
Hill, 2002, J Clin Exp Neuropsychol, 24, 765, 10.1076/jcen.24.6.765.8402
Hill, 2004, Schizophr Res, 68, 127, 10.1016/S0920-9964(03)00125-7
Hill, 2004, Schizophr Res, 68, 49, 10.1016/S0920-9964(03)00213-5
Hill, 2008, Schizophr Bull, 34, 743, 10.1093/schbul/sbn027
Smith, 2011, Psychopharmacology (Berl), 217, 255, 10.1007/s00213-011-2277-5
Young, 2009, Pharmacol Ther, 122, 150, 10.1016/j.pharmthera.2009.02.004
Dunnett, 1985, Psychopharmacology (Berl), 87, 357, 10.1007/BF00432721
Barch, 2009, Schizophr Bull, 35, 136, 10.1093/schbul/sbn153
Barch, 2009, Schizophr Bull, 35, 109, 10.1093/schbul/sbn163
Johnson, 2006, Curr Opin Pharmacol, 6, 61, 10.1016/j.coph.2005.09.007
Braff, 1978, Psychophysiology, 15, 339, 10.1111/j.1469-8986.1978.tb01390.x
Braff, 2001, Psychopharmacology (Berl), 156, 234, 10.1007/s002130100810
Ison, 1971, J Comp Physiol Psychol, 75, 435, 10.1037/h0030934
Mansbach, 1989, Neuropsychopharmacology, 2, 299, 10.1016/0893-133X(89)90035-3
Mansbach, 1991, Eur J Pharmacol, 202, 61, 10.1016/0014-2999(91)90253-M
Mansbach, 1991, Psychopharmacology (Berl), 105, 162, 10.1007/BF02244303
Martinez, 1999, Neuropsychopharmacology, 21, 28, 10.1016/S0893-133X(98)00137-7
Rogawski, 1993, Trends Pharmacol Sci, 14, 325, 10.1016/0165-6147(93)90005-5
Danysz, 1995, Behav Pharmacol, 6, 455
Rogawski, 2000, Amino Acids, 19, 133, 10.1007/s007260070042
Wiley, 2003, Psychopharmacology (Berl), 165, 378, 10.1007/s00213-002-1297-6
Swerdlow, 2009, Neuropsychopharmacology, 34, 1854, 10.1038/npp.2009.7
Petrović, 2005, Prague Med Rep, 106, 113
Duncan, 1998, Brain Res, 812, 65, 10.1016/S0006-8993(98)00926-3
Dedeurwaerdere, 2011, Psychopharmacology (Berl), 214, 505, 10.1007/s00213-010-2052-z
Sokoloff, 1977, J Neurochem, 28, 897, 10.1111/j.1471-4159.1977.tb10649.x
Seki, 1993, J Neurosci, 13, 2351, 10.1523/JNEUROSCI.13-06-02351.1993
Seki, 1995, Neuroreport, 6, 2479, 10.1097/00001756-199512150-00010
Ming, 2005, Annu Rev Neurosci, 28, 223, 10.1146/annurev.neuro.28.051804.101459
Namba, 2011, J Neurochem, 118, 34, 10.1111/j.1471-4159.2011.07282.x
Javitt, 2004, Mol Psychiatry, 9, 984, 10.1038/sj.mp.4001551
Tsai, 2010, Curr Pharm Des, 16, 522, 10.2174/138161210790361452
Berger, 2003, Psychopharmacol Bull, 37, 79
Reisberg, 2003, N Engl J Med, 348, 1333, 10.1056/NEJMoa013128
Verma, 1996, J Neurosci, 16, 373, 10.1523/JNEUROSCI.16-01-00373.1996
Lisman, 1998, Nat Neurosci, 1, 273, 10.1038/1086
Thomas, 2005, Am J Psychiatry, 162, 626, 10.1176/appi.ajp.162.3.626
Carpenter, 2006, Ann Pharmacother, 40, 344, 10.1345/aph.1G297
Carroll, 2006, Ann Clin Psychiatry, 18, 133, 10.1080/10401230600614710
Pondé, 2007, Rev Bras Psiquiatr, 29, 92, 10.1590/S1516-44462007000100028
Cerullo, 2007, Schizophr Res, 97, 294, 10.1016/j.schres.2007.07.034
Krivoy, 2008, Eur Neuropsychopharmacol, 18, 117, 10.1016/j.euroneuro.2007.07.008
Lieberman, 2009, Neuropsychopharmacology, 3, 1322, 10.1038/npp.2008.200
de Lucena, 2011, Erratum in: J Clin Psychiatry, 72, 1157, 10.4088/JCP.11lr07077a
de Lucena, 2010, J Clin Psychiatry, 71, 91, 10.4088/JCP.09l05388
Xiu, 2009, Prog Neuropsychopharmacol Biol Psychiatry, 33, 1508, 10.1016/j.pnpbp.2009.08.011
Gray, 2009, Int J Neuropsychopharmacol, 12, 45, 10.1017/S1461145708009085
Fornaro, 2011, Cent Nerv Syst Agents Med Chem, 11, 73, 10.2174/187152411794961031
Carroll, 2007, J Neuropsychiatry Clin Neurosci, 19, 406, 10.1176/appi.neuropsych.19.4.406
Obregon, 2011, J Psychiatr Pract, 17, 292, 10.1097/01.pra.0000400268.60537.5e
Feusner, 2009, Psychopharmacology Bull, 42, 81
Wu, 2012, Pharmacol Biochem Behav, 100, 726, 10.1016/j.pbb.2011.10.007
Egashira, 2008, Eur J Pharmacol, 586, 164, 10.1016/j.ejphar.2008.01.035
Wald, 2009, Exp Clin Psychopharmacol, 17, 191, 10.1037/a0016402
Poyurovsky, 2005, Am J Psychiatry, 162, 2191, 10.1176/appi.ajp.162.11.2191-a
Pasquini, 2006, Prog Neuropsychopharmacol Biol Psychiatry, 30, 1173, 10.1016/j.pnpbp.2006.04.013
Hezel, 2009, Am J Psychiatry, 166, 237, 10.1176/appi.ajp.2008.08091427
Aboujaoude, 2009, J Clin Psychopharmacol, 29, 51, 10.1097/JCP.0b013e318192e9a4
Stewart, 2010, J Clin Psychopharmacol, 30, 34, 10.1097/JCP.0b013e3181c856de
Adamec, 1997, Neurosci Biobehav Rev, 21, 755, 10.1016/S0149-7634(96)00055-3
Harvey, 2005, Hum Psychopharmacol, 20, 367, 10.1002/hup.695
Battista, 2007, Psychiatry, 70, 167, 10.1521/psyc.2007.70.2.167
Chopra, 2011, J Clin Psychopharmacol, 31, 787, 10.1097/JCP.0b013e31823657bf
Dannon, 2006, Prim Care Companion J Clin Psychiatry, 8, 334, 10.4088/PCC.v08n0603
Potenza, 2008, Philos Trans R Soc Lond B Biol Sci, 363, 3181, 10.1098/rstb.2008.0100
Goudriaan, 2010, Addict Biol, 15, 491, 10.1111/j.1369-1600.2010.00242.x
Brewer, 2008, Biochem Pharmacol, 75, 63, 10.1016/j.bcp.2007.06.043
Reuter, 2005, Nat Neurosci, 8, 147, 10.1038/nn1378
Nussbaum, 2011, J Gambl Stud, 27, 523, 10.1007/s10899-010-9219-8
Olive, 2012, Pharmacol Biochem Behav, 100, 801, 10.1016/j.pbb.2011.04.015
Winstanley, 2011, Br J Pharmacol, 164, 1301, 10.1111/j.1476-5381.2011.01323.x
Nordin, 2007, Neuropsychobiology, 56, 152, 10.1159/000115782
Meroni, 2004, J Clin Psychopharmacol, 24, 350, 10.1097/01.jcp.0000126666.83068.a9
Roncero, 2009, Actas Esp Psiquiatr, 37, 205
Grant, 2011, Erratum in: Br J Psychiatry, 198, 75
Grant, 2007, Biol Psychiatry, 62, 652, 10.1016/j.biopsych.2006.11.021
Saiz-Ruiz, 2005, J Clin Psychiatry, 66, 28, 10.4088/JCP.v66n0104
Stanley, 2011, Physiol Behav, 104, 40, 10.1016/j.physbeh.2011.04.046
Reddy, 1998, Psychopharmacology (Berl), 137, 391, 10.1007/s002130050635
Tsuda, 1998, Brain Res, 790, 82, 10.1016/S0006-8993(98)00052-3
Blevins, 2004, Brain Res, 1019, 124, 10.1016/j.brainres.2004.05.089
Popik, 2011, Amino Acids, 40, 477, 10.1007/s00726-010-0659-3
Bisaga, 2008, Eur Neuropsychopharmacol, 18, 794, 10.1016/j.euroneuro.2008.05.004
Koronyo-Hamaoui, 2007, J Psychiatr Res, 41, 160, 10.1016/j.jpsychires.2005.07.010
Mills, 1998, QJM, 91, 493, 10.1093/qjmed/91.7.493
Hermanussen, 2005, Econ Hum Biol, 3, 329, 10.1016/j.ehb.2005.04.001
Brennan, 2008, Int J Eat Disord, 41, 520, 10.1002/eat.20541
Zdanys, 2008, Prog Neuropsychopharmacol Biol Psychiatry, 32, 1362, 10.1016/j.pnpbp.2008.01.008
Gass, 2008, Biochem Pharmacol, 75, 218, 10.1016/j.bcp.2007.06.039
Bisaga, 2010, Drug Alcohol Depend, 111, 97, 10.1016/j.drugalcdep.2010.04.006
Parsons, 2005, Handb Exp Pharmacol, &NA;, 249
Nadler, 1990, Eur J Pharmacol, 188, 97, 10.1016/0922-4106(90)90044-X
MacDonald, 1991, J Physiol, 432, 483, 10.1113/jphysiol.1991.sp018396
Schummers, 2001, Mol Brain Res, 94, 9, 10.1016/S0169-328X(01)00161-9
Krupitsky, 2007, Alcohol Clin Exp Res, 31, 604, 10.1111/j.1530-0277.2007.00344.x
Bisaga, 2004, Psychopharmacology (Berl), 172, 16, 10.1007/s00213-003-1617-5
Krupitsky, 2007, Am J Psychiatry, 164, 519, 10.1176/appi.ajp.164.3.519
Cornish, 1999, Neuroscience, 93, 1359, 10.1016/S0306-4522(99)00214-6
Hotsenpiller, 2001, Eur J Neurosci, 14, 1843, 10.1046/j.0953-816x.2001.01804.x
Hayes, 2003, Psychopharmacology (Berl), 168, 75, 10.1007/s00213-002-1328-3
Vorel, 2001, Science, 292, 1175, 10.1126/science.1058043
Kelamangalath, 2007, Behav Brain Res, 185, 119, 10.1016/j.bbr.2007.08.001
Collins, 2006, Pharmacol Biochem Behav, 83, 47, 10.1016/j.pbb.2005.12.003
Collins, 2007, Exp Clin Psychopharmacol, 15, 228, 10.1037/1064-1297.15.3.228
Collins, 1998, Behav Pharmacol, 9, 587, 10.1097/00008877-199811000-00014
Trujillo, 1991, Pharmacol Biochem Behav, 38, 673, 10.1016/0091-3057(91)90032-W
Vandergriff, 1999, Neuropharmacology, 38, 217, 10.1016/S0028-3908(98)00196-8
Rasmussen, 2004, Neuropharmacology, 46, 620, 10.1016/j.neuropharm.2003.11.013
Rasmussen, 2003, Neuropharmacology, 44, 88, 10.1016/S0028-3908(02)00296-4
Tokuyama, 2001, Neurochem Int, 39, 103, 10.1016/S0197-0186(01)00019-5
Wang, 2004, Prog Neuropsychopharmacol Biol Psychiatry, 28, 1079, 10.1016/j.pnpbp.2004.05.043
Wang, 1994, Brain Res, 666, 255, 10.1016/0006-8993(94)90780-3
Wang, 1995, Brain Res Bull, 36, 39, 10.1016/0361-9230(94)00160-3
Bisaga, 2001, Psychopharmacology (Berl), 157, 1, 10.1007/s002130100739
Krupitsky, 2002, Addictive Disorders & Their Treatment, 1, 143, 10.1097/00132576-200211000-00006
Bisaga, 2011, Drug Alcohol Depend, 119, e23, 10.1016/j.drugalcdep.2011.05.019
Arias, 2007, Addictive Disorders & Their Treatment, 6, 77, 10.1097/01.adt.0000210724.41187.4a
Evans, 2007, Alcohol Clin Exp Res, 31, 775, 10.1111/j.1530-0277.2007.00360.x
Muhonen, 2009, Psychiatry Res, 167, 115, 10.1016/j.psychres.2008.05.001
Muhonen, 2011, Psychiatry Res, 186, 53, 10.1016/j.psychres.2010.07.039
Thuerauf, 2007, J Neural Transm, 114, 351, 10.1007/s00702-006-0570-y
Carlsson, 2000, Acta Psychiatr Scand, 102, 401, 10.1034/j.1600-0447.2000.102006401.x
Carlsson, 2001, Prog Neuropsychopharmacol Biol Psychiatry, 25, 5, 10.1016/S0278-5846(00)00146-9
Carrey, 2007, J Child Adolesc Psychopharmacol, 17, 11, 10.1089/cap.2006.0008
Perlov, 2007, J Psychiatr Res, 41, 934, 10.1016/j.jpsychires.2006.12.007
Carrey, 2002, J Child Adolesc Psychopharmacol, 12, 331, 10.1089/104454602762599871
Russell, 2003, Neurosci Biobehav Rev, 27, 671, 10.1016/j.neubiorev.2003.08.010
Warton, 2009, Metab Brain Dis, 24, 599, 10.1007/s11011-009-9166-1
Jensen, 2009, Neuroscience, 158, 353, 10.1016/j.neuroscience.2008.05.016
Lehohla, 2004, Metab Brain Dis, 19, 35, 10.1023/B:MEBR.0000027415.75432.ad
Pozzi, 2011, Neuroscience, 176, 336, 10.1016/j.neuroscience.2010.11.060
Turic, 2004, Mol Psychiatry, 9, 169, 10.1038/sj.mp.4001387
Dorval, 2007, Genes Brain Behav, 6, 444, 10.1111/j.1601-183X.2006.00273.x
Adams, 2004, Mol Psychiatry, 9, 494, 10.1038/sj.mp.4001455
Marusich, 2011, Behav Pharmacol, 22, 794, 10.1097/FBP.0b013e32834d623e
Sukhanov, 2004, Behav Pharmacol, 15, 263, 10.1097/01.fbp.0000137212.03247.f1
Findling, 2007, J Child Adolesc Psychopharmacol, 17, 19, 10.1089/cap.2006.0044
